Platelet–Neutrophil Interaction and Thromboinflammation in Diabetes: Considerations for Novel Therapeutic Approaches
Thromboinflammation has become a topic of key interest in cardiovascular disease and the prevention of diabetes complications because of the interplay between thrombosis and inflammation in diabetes. Specifically, the significant risk of vascular thrombotic disease in diabetes highlights the need fo...
Main Authors: | Julia S. Gauer, Ramzi A. Ajjan, Robert A. S. Ariëns |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-10-01
|
Series: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
Subjects: | |
Online Access: | https://www.ahajournals.org/doi/10.1161/JAHA.122.027071 |
Similar Items
-
Thromboinflammation Model-on-A-Chip by Whole Blood Microfluidics on Fixed Human Endothelium
by: Alexander Dupuy, et al.
Published: (2021-01-01) -
Platelet <i>Versus</i> Megakaryocyte: Who Is the Real Bandleader of Thromboinflammation in Sepsis?
by: Cédric Garcia, et al.
Published: (2022-04-01) -
P2X1: a unique platelet receptor with a key role in thromboinflammation
by: Cécile Oury, et al.
Published: (2021-10-01) -
Selective inhibition of thromboinflammation in COVID-19 by Btk inhibitors
by: Wolfgang Siess, et al.
Published: (2020-11-01) -
A rationale for blocking thromboinflammation in COVID-19 with Btk inhibitors
by: Phillip LR. Nicolson, et al.
Published: (2020-07-01)